Utility of Cerebrospinal Fluid Cytology in Newly Diagnosed Childhood Ependymoma

被引:7
作者
Moreno, Lucas [1 ]
Pollack, Ian F. [2 ]
Duffner, Patricia K. [3 ]
Geyer, J. Russell [4 ]
Grill, Jacques [6 ]
Massimino, Maura [7 ]
Finlay, Jonathan L. [5 ]
Zacharoulis, Stergios [1 ]
机构
[1] Royal Marsden NHS Fdn Trust, Dept Paediat, Sutton SM2 5PT, Surrey, England
[2] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA
[3] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA
[4] Childrens Hosp & Reg Med Ctr, Dept Pediat Hematol Oncol, Seattle, WA USA
[5] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Neural Tumors Program, Los Angeles, CA USA
[6] Inst Gustave Roussy, Dept Pediat & Adolescent Oncol, Villejuif, France
[7] Ist Nazl Tumori, Div Pediat Oncol, I-20133 Milan, Italy
关键词
metastatic ependymoma; CSF cytology; prognosis; PROGNOSTIC-FACTORS; INTRACRANIAL EPENDYMOMAS; PEDIATRIC MEDULLOBLASTOMA; LEPTOMENINGEAL DISEASE; YOUNG-CHILDREN; BRAIN-TUMORS; CSF CYTOLOGY; CHEMOTHERAPY; RADIOTHERAPY; INFANTS;
D O I
10.1097/MPH.0b013e3181d7adf5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The role of cytology of cerebrospinal fluid (CSF) has not been established in pediatric ependymoma. Thirty-two children with metastatic ependymoma were analyzed: 11 patients had only positive CSF cytology, 6 had only positive magnetic resonance imaging (MRI) findings, and 15 had both CSF cytology and MRI positive. Twenty-two patients relapsed. Five-year event-free survival was 27.3% +/- 13.4% for children with only CSF positive (M1) versus 26.1% +/- 10.2% for patients with positive spine MRI positive (with or without CSF positive, M3) (P = 0.87). In conclusion, 34% of the patients with metastatic ependymoma were identified based on CSF cytology only and their outcome was comparable to patients with macroscopic disease. CSF cytology is a useful tool to stage newly diagnosed patients with ependymoma.
引用
收藏
页码:515 / 518
页数:4
相关论文
共 21 条
  • [1] Almeida Sérgio M. de, 2007, Arq. Neuro-Psiquiatr., V65, P802, DOI 10.1590/S0004-282X2007000500014
  • [2] Prognostic factors in infants and very young children with intracranial ependymomas
    Duffner, PK
    Kischer, JP
    Sanford, RA
    Horowitz, ME
    Burger, PC
    Cohen, ME
    Friedman, HS
    Kun, LE
    [J]. PEDIATRIC NEUROSURGERY, 1998, 28 (04) : 215 - 222
  • [3] Comparison of CSF cytology and spinal magnetic resonance imaging in the detection of leptomeningeal disease in pediatric medulloblastoma or primitive neuroectodermal tumor
    Fouladi, M
    Gajjar, A
    Boyett, JM
    Walter, AW
    Thompson, SJ
    Merchant, TE
    Jenkins, JJ
    Langston, LW
    Liu, AY
    Kun, LE
    Heideman, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) : 3234 - 3237
  • [4] Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumors
    Gajjar, A
    Fouladi, M
    Walter, AW
    Thompson, SJ
    Reardon, DA
    Merchant, TE
    Jenkins, JJ
    Liu, AY
    Boyett, JM
    Kun, LE
    Heideman, RL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) : 1825 - 1828
  • [5] Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: A report from the children's cancer group
    Geyer, JR
    Sposto, R
    Jennings, M
    Boyett, JM
    Axtell, RA
    Breiger, D
    Broxson, E
    Donahue, B
    Finlay, JL
    Goldwein, LW
    Heier, LA
    Johnson, D
    Mazewski, C
    Miller, DC
    Packer, R
    Puccetti, D
    Radcliffe, J
    Tao, ML
    Shiminski-Maher, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) : 7621 - 7631
  • [6] Glantz MJ, 1998, CANCER, V82, P733, DOI 10.1002/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO
  • [7] 2-Z
  • [8] MALIGNANT-CELLS IN CEREBROSPINAL-FLUID (CSF) - MEANING OF A POSITIVE CSF CYTOLOGY
    GLASS, JP
    MELAMED, M
    CHERNIK, NL
    POSNER, JB
    [J]. NEUROLOGY, 1979, 29 (10) : 1369 - 1375
  • [9] Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: A multicenter trial of the French Society of Pediatric Oncology
    Grill, J
    Le Deley, MC
    Gambarelli, D
    Raquin, MA
    Couanet, D
    Pierre-Kahn, A
    Habrand, JL
    Doz, F
    Frappaz, D
    Gentet, JC
    Edan, C
    Chastagner, P
    Kalifa, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) : 1288 - 1296
  • [10] Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma:: Final results of the first prospective AIEOP (Associazione Italiana Di Ematologiaoncologia Pediatrica) study
    Massimino, M
    Gandola, L
    Giangaspero, F
    Sandri, A
    Valagussa, P
    Perilongo, G
    Garrè, ML
    Ricardi, U
    Forni, M
    Genitori, L
    Scarzello, G
    Spreafico, F
    Barra, S
    Mascarin, M
    Pollo, B
    Gardiman, M
    Cama, A
    Navarria, P
    Brisigotti, M
    Collini, P
    Balter, R
    Fidani, P
    Stefanelli, M
    Burnelli, R
    Potepan, P
    Podda, M
    Sotti, G
    Madon, E
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1336 - 1345